Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone
Clinical trial NCT01450761 · COMPLETED
Trial details
- NCT number
- NCT01450761
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-13
- Primary completion
- 2015-03-19
- Enrollment
- 1351
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.